Log in to your IBTimes Account

close
ID
Password

CFO for Endo Pharmaceuticals resigns



By AP
02 September 2008 @ 06:40 pm EST

NEW YORK - Endo Pharmaceuticals said Tuesday its Chief Financial Officer Charles Rowland has resigned to pursue other interests.

Related Topic

Get stories by e-mail on this topic.

  • ENDP | RSS
  • Endo | RSS
  • Pharmaceuticals | RSS
  • Personnel | RSS
E-mail:
Quotes
ENDP 21.99 0.85

SYMBOL LOOKUP

Rowland's resignation takes effect immediately, and the company did not announce a replacement. The Chadds Ford, Pa.-based company said it has tapped an outside firm to help find a new financial chief.

Shares of Endo Pharmaceuticals fell 20 cents Tuesday to close at $22.52.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register


advertisement
More Industries
Pacific Investment Management Company Inc. on Monday canceled announced dividend payments for six of its funds, saying the weak market has pushed the val...
Alkermes Inc. announced Monday it has regained full commercialization rights in the United States for the alcoholism treatment Vivitrol. The biotechnolog...
Ford Motor Co. says it is considering selling Volvo Car Corp. as the struggling U.S. automaker seeks to raise cash and weather the industry crisis. Ford ...

Advertisement
Los angeles web design

Get your next web design project done with our los angeles web design team - Best web design with great price.

Reach emerging Latin American markets!

Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish

Build Business Credit for your company with NO PERSONAL GUARANTEES!

Building your business and corporate credit for your small business.

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives